Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Leuprorelin 11.25mg implant pre-filled syringes |
| BNF code | 0803042N0AAAFAF |
| Virtual Therapeutic Moiety | Leuprorelin |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 1 May 2024 |
| Previous name | Leuprorelin 10.72mg implant pre-filled syringes |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | pre-filled disposable injection |
| Unit dose unit of measure | pre-filled disposable injection |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Leuprorelin acetate |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 11.250 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | implant.subcutaneous |
| Dose Form | |
| Formulation | Prolonged-release subcutaneous implant |
| Drug Route | |
| Route | Subcutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Staladex 11.25mg implant pre-filled syringes (Aspire Pharma Ltd) | |
| Virtual Medicinal Product Packs | |
| Leuprorelin 11.25mg implant pre-filled syringes 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.